General Virology encompasses the study of viruses, microscopic infectious agents that can cause a wide range of diseases in humans, animals, plants, and even bacteria. Some viruses also have an outer envelope derived from the host cell membrane. Virologists study various aspects of viruses, including their structure, replication, transmission, pathogenesis, and evolution. Understanding these fundamental aspects of virology is crucial for the development of vaccines to prevent viral infections.
Vaccines work by stimulating the body's immune system to recognize and respond to specific viral antigens, such as viral proteins or surface molecules. By mimicking natural infection without causing illness, vaccines prime the immune system to produce antibodies and memory cells that provide long-lasting protection against future encounters with the virus. There are several types of vaccines, including live attenuated vaccines, inactivated vaccines, subunit vaccines, recombinant vaccines, and nucleic acid vaccines. Each type of vaccine utilizes different strategies to present viral antigens to the immune system and induce a protective immune response.
Live attenuated vaccines contain weakened forms of the virus that can still replicate but cause minimal or no disease. Inactivated vaccines contain viruses that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are safe but may require booster doses to maintain immunity. Subunit vaccines contain purified viral antigens or protein subunits that stimulate an immune response. These vaccines are highly purified and do not contain live virus, making them safe for use in individuals with weakened immune systems. Recombinant vaccines are produced by genetically engineering viruses to express specific antigens. These vaccines are highly specific and can be tailored to target specific viral proteins or surface molecules. Examples include the recombinant hepatitis B vaccine and the recombinant subunit vaccine against COVID-19.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India